Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The first 100 days of SARS-CoV-2 control in Vietnam

Pham Quang Thai, Maia A Rabaa, Duong Huy Luong, Dang Quang Tan, Tran Dai Quang, Ha-Linh Quach, Ngoc-Anh Hoang Thi, Phung Cong Dinh, Ngu Duy Nghia, Tran Anh Tu, La Ngoc Quang, Tran My Phuc, Vinh Chau, Nguyen Cong Khanh, Dang Duc Anh, Tran Nhu Duong, Guy Thwaites, H Rogier van Doorn, Marc Choisy, OUCRU COVID-19 Research Group
doi: https://doi.org/10.1101/2020.05.12.20099242
Pham Quang Thai
1National Institute of Hygiene and Epidemiology, Vietnam
2School of Preventive Medicine and Public Health, Hanoi Medical University, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maia A Rabaa
3Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, UK
4Oxford University Clinical Research Unit, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Duong Huy Luong
5Medical Services Administration, Ministry of Health, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dang Quang Tan
6General Department of Preventive Medicine, Ministry of Health, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tran Dai Quang
6General Department of Preventive Medicine, Ministry of Health, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ha-Linh Quach
1National Institute of Hygiene and Epidemiology, Vietnam
7Research School of Population Health, Australian National University, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ngoc-Anh Hoang Thi
1National Institute of Hygiene and Epidemiology, Vietnam
7Research School of Population Health, Australian National University, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phung Cong Dinh
8National Agency for Science and Technology Information, Ministry of Science and Technology, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ngu Duy Nghia
1National Institute of Hygiene and Epidemiology, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tran Anh Tu
1National Institute of Hygiene and Epidemiology, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
La Ngoc Quang
9Hanoi University of Public Health, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tran My Phuc
4Oxford University Clinical Research Unit, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vinh Chau
4Oxford University Clinical Research Unit, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nguyen Cong Khanh
1National Institute of Hygiene and Epidemiology, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dang Duc Anh
1National Institute of Hygiene and Epidemiology, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dda@nihe.org.vn
Tran Nhu Duong
1National Institute of Hygiene and Epidemiology, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guy Thwaites
3Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, UK
4Oxford University Clinical Research Unit, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H Rogier van Doorn
3Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, UK
4Oxford University Clinical Research Unit, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Choisy
3Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, UK
4Oxford University Clinical Research Unit, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background One hundred days after SARS-CoV-2 was first reported in Vietnam on January 23rd, 270 cases have been confirmed, with no deaths. We describe the control measures used by the Government and their relationship with imported and domestically-acquired case numbers, with the aim of identifying the measures associated with successful SARS-CoV-2 control.

Methods Clinical and demographic data on the first 270 SARS-CoV-2 infected cases and the timing and nature of Government control measures, including numbers of tests and quarantined individuals, were captured by Vietnam’s National Steering Committee for COVID-19 response. Apple and Google mobility data provided proxies for population movement. Serial intervals were calculated from 33 infector-infectee pairs and used to estimate the proportion of pre-symptomatic transmission events and time-varying reproduction numbers.

Findings After the first confirmed case on January 23rd, the Vietnamese Government initiated mass communications measures, case-contact tracing, mandatory 14-day quarantine, school and university closures, and progressive flight restrictions. A national lockdown was implemented between April 1st and 22nd. Around 200 000 people were quarantined and 266 122 RT-PCR tests conducted. Population mobility decreased progressively before lockdown. 60% (163/270) of cases were imported; 43% (89/208) of resolved infections remained asymptomatic for the duration of infection. 21 developed severe disease, with no deaths. The serial interval was 3.24 days, and 27.5% (95% confidence interval, 15.7%-40.0%) of transmissions occurred pre-symptomatically. Limited transmission amounted to a maximum reproduction number of 1.15 (95% confidence interval, 0.37-2.36). No community transmission has been detected since April 15th.

Interpretation Vietnam has controlled SARS-CoV-2 spread through the early introduction of mass communication, meticulous contact-tracing with strict quarantine, and international travel restrictions. The value of these interventions is supported by the high proportion of asymptomatic and imported cases, and evidence for substantial pre-symptomatic transmission.

Funding The Vietnam Ministry of Health and Wellcome Trust, UK.

Evidence before this study Vietnam was one of the first countries outside of China to detect imported and human-to-human transmitted SARS-CoV-2 within its borders. Yet, as of May 1st, a total of only 270 cases have been confirmed, no deaths have occurred, and no community transmission has been detected since April 15th despite intensive screening, tracing and testing. We did a PubMed database search to identify studies investigating COVID-19 response in Vietnam using the terms “Vietnam”, “COVID-19”, and “SARS-CoV-2”. All relevant articles were evaluated. Studies describe cases of COVID-19 and their management, aspects of the government response from newspapers and online government sources, but there are no previous reports using national data to describe and investigate the national epidemic and the impact of control measures cases over time.

Added value of this study We used data from the National Steering Committee for COVID-19 response to give a comprehensive account of the first 100 days of the SARS-CoV-2 epidemic in Vietnam, including case numbers and their symptomatology, the estimated reproductive number by week, and their relation to the multiple control measures instituted by the Vietnam Government over time. We show two distinctive features of Vietnam’s response. First, the Government took rapid actions to restrict international flights, closed schools and universities, and instituted meticulous case-contact tracing and quarantining from late January, well before these measures were advised by WHO. Second, they placed mass communication, education, and the identification, serial testing, and 14-day quarantine of all direct contacts of cases, regardless of symptom development, at the heart of the response. The value of strict contact-tracing and quarantine is supported by the high proportion of asymptomatic cases (43%) and imported cases (60%), and evidence for substantial pre-symptomatic transmission.

Implications of all the available evidence Vietnam has had remarkable success in controlling the emergence of SARS-CoV-2. Our report provides a complete picture of the control of SARS-CoV-2 in Vietnam, with lessons for other Governments seeking to extend national SARS-CoV-2 control or prevent future epidemics. Our findings shows the importance of acting early, before the virus becomes established in the community, and before the case numbers overwhelm systems of case-contact tracing and mass quarantine. They also demonstrate the value of effective mass communication in rapidly educating the public in infection prevention measures and providing real-time information on the state of the epidemic.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Research supported by the Wellcome Trust

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data available upon request

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 19, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The first 100 days of SARS-CoV-2 control in Vietnam
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The first 100 days of SARS-CoV-2 control in Vietnam
Pham Quang Thai, Maia A Rabaa, Duong Huy Luong, Dang Quang Tan, Tran Dai Quang, Ha-Linh Quach, Ngoc-Anh Hoang Thi, Phung Cong Dinh, Ngu Duy Nghia, Tran Anh Tu, La Ngoc Quang, Tran My Phuc, Vinh Chau, Nguyen Cong Khanh, Dang Duc Anh, Tran Nhu Duong, Guy Thwaites, H Rogier van Doorn, Marc Choisy, OUCRU COVID-19 Research Group
medRxiv 2020.05.12.20099242; doi: https://doi.org/10.1101/2020.05.12.20099242
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
The first 100 days of SARS-CoV-2 control in Vietnam
Pham Quang Thai, Maia A Rabaa, Duong Huy Luong, Dang Quang Tan, Tran Dai Quang, Ha-Linh Quach, Ngoc-Anh Hoang Thi, Phung Cong Dinh, Ngu Duy Nghia, Tran Anh Tu, La Ngoc Quang, Tran My Phuc, Vinh Chau, Nguyen Cong Khanh, Dang Duc Anh, Tran Nhu Duong, Guy Thwaites, H Rogier van Doorn, Marc Choisy, OUCRU COVID-19 Research Group
medRxiv 2020.05.12.20099242; doi: https://doi.org/10.1101/2020.05.12.20099242

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (180)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (949)
  • Dentistry and Oral Medicine (178)
  • Dermatology (111)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (423)
  • Epidemiology (9004)
  • Forensic Medicine (4)
  • Gastroenterology (421)
  • Genetic and Genomic Medicine (1962)
  • Geriatric Medicine (191)
  • Health Economics (405)
  • Health Informatics (1330)
  • Health Policy (662)
  • Health Systems and Quality Improvement (520)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10826)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1837)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (356)
  • Occupational and Environmental Health (470)
  • Oncology (1003)
  • Ophthalmology (299)
  • Orthopedics (111)
  • Otolaryngology (183)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (582)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1910)
  • Public and Global Health (4133)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (370)
  • Respiratory Medicine (551)
  • Rheumatology (226)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (178)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (82)